...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives
【24h】

Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives

机译:肠道微生物群和阿尔茨海默病之间的关联:当前证据和未来的治疗和诊断观点

获取原文
获取原文并翻译 | 示例
           

摘要

Developing novel agents for unexplored targets to combat Alzheimer's disease (AD) represents an urgent task due to its increasing prevalence worldwide. The present paper summarizes the latest studies emerged in the past few years investigating the associations between the "forgotten organ" gut microbiota and AD from the following two aspects: 1) the associations between gut microbiota and AD development by animal models and human studies; and 2) the effects of gut microbiota modulation-based intervention for AD. Then, we propose future perspectives in two promising research areas: 1) developing gut microbiota modulation-based intervention; and 2) developing gut microbiota-associated diagnostic biomarkers for AD. Knowledge gaps and potential barriers to overcome towards these two goals are also discussed.
机译:为未开发的未探究目标进行打击的目标的新型代理(AD)代表着普遍普遍的普遍性,这是一个紧急的任务。 本文总结了过去几年中出现的最新研究,调查“被遗忘的器官”肠道微生物群和广告之间的协会从以下两个方面进行:1)肠道微生物群和动物模型和人类研究的广告开发之间的关联; 2)Gut Microbiota调制基于AD的疗效。 然后,我们提出了两个有前途的研究领域的未来观点:1)制定肠道微生物群调制的干预; 2)开发肠道微生物群相关的AD诊断生物标志物。 还讨论了知识差距以及克服这两个目标的潜在障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号